2023-08-30 09:07:03 ET
More on Dare Bioscience
- Daré Bioscience, Inc. 2023 Q2 - Results - Earnings Call Presentation
- Daré Bioscience, Inc. ( DARE ) Q2 2023 Earnings Call Transcript
- Daré Bioscience hits seven-month high after regaining listing compliance
- Daré gets Gates Foundation grant to develop Hydrogel tech for use in vaginal health
- Daré rises on positive data from early-to-mid-stage trial of intravaginal ring to treat menopause symptoms
- Dare Bioscience reports positive progress for cream for female sexual arousal disorder
- Seeking Alpha’s Quant Rating on Dare Bioscience
- Earnings data for Dare Bioscience
For further details see:
Dare Bioscience to sell 10M shares at $0.70 in registered direct offering